In fact, NRF2 pathway in prostate cancer cells can be regulated by SETD7, a lysine methyltransferases that can add methyl groups to the lysine 4 on histone H3 (H3K4) favoring transcriptional activation [58,59,60]. Here, NFE2L2 is linked to prostate cancer.